You are here: 


The Canadian Cancer Society’s national office and each of its provincial offices are accountable to a volunteer board of directors. The board’s responsibilities include governance, leadership, public accountability, establishing the Society’s nation-wide and provincial priorities and acting as a trustee on behalf of Canadians.

  • Board of Directors

    Robert Lawrie (Chair)
    Toronto, ON

    Wayne McDonald
    Riverview, NB

    Rob Assimakopoulos
    Toronto, ON

    Nancy McKay
    Fredericton, NB

    John Boynton
    Toronto, ON

    Dr John Mercer
    Edmonton, AB

    Susan Ewanick
    West Kelowna, BC

    James Moore
    Port Moody, BC

    Dr David Huntsman
    Vancouver, BC

    Patricia North
    Toronto, ON

    Dr Michael Jewett
    Toronto, ON

    Bruce Rothney
    Toronto, ON

    Shachi Kurl
    Vancouver, BC

    Gail Rudderham Chernin
    Sydney, NS

    Dr David Malkin
    Toronto, ON

    Yves A Sicard
    Saint-Lambert, QC

    Bretta Maloff
    Calgary, AB

    Dr Michael Woods
    St. John's, NL

  • A message from the Chair of our Board of Directors
    Robert Lawrie

    2017-18 was historic for the Canadian Cancer Society (CCS). Our merger with the Canadian Breast Cancer Foundation brought together 2 of the largest health charities in Canada in a bold move which provided resources more efficiently to deliver on our combined mission.

    Knowing nearly half of Canadians will be diagnosed with cancer in our lifetimes and forecasting the incidence of the disease to rise dramatically by 2030, CCS needed to address this surge with new strategies. While we will continue to be the largest charitable underwriter of cancer research and to offer trusted and compassionate information and support to patients and their clinical and personal supporters, we are also embarking on several new initiatives seeking to prevent cancer by conducting research into healthier living and advocating those choices directly and through public policies.

    More than ever, CCS is contributing to the eradication of cancer through research and prevention. Until then, we will make every effort to assist those of us whose lives are impacted – patients, families, supporting caregivers, clinicians and researchers.

    On behalf of the Board of Directors, thank you to our leadership, donors and volunteers. This transformative year could not have happened without your support.

    Robert Lawrie

  • Executive Leadership Team

    Andrea Seale
    Interim Chief Executive Officer

    Paula Roberts
    Executive Vice-President, Marketing and Communications

    Sara Oates
    Executive Vice-President, Finance and Operations

    Debbie Singh
    Executive Vice-President, People and Culture

    Jeff Cornett
    Executive Director, Ontario

    Sandra Krueckl
    Vice President, Cancer Control, Chair of Mission

    Denis Lalonde
    Executive Director, Quebec

    Jane Parsons
    Regional Executive Director, Atlantic

    Dan Holinda
    Regional Executive Director, Prairies

    Andrea Seale
    Regional Executive Director, BC/Yukon

    Faye Wightman
    Interim Executive Director, British Columbia and Yukon

    Contact a member of our senior leadership team at

  • PEI Advisory Board

    Charles Keliher (Chair)
    Charlottetown, PE

    Ben Parsons
    Charlottetown, PE

    Liz Dobbin
    Little York, PE

    Arlene Rose
    Souris, PE

    Barbara Scales
    Charlottetown, PE

    Mark Simmons
    Summerside, PE

    Jessica Gillis
    Charlottetown, PE

    Barbara E. Smith
    Charlottetown, PE

    Glenn Trueman
    Charlottetown, PE

    Shauna Sullivan-Curley
    Charlottetown, PE

    Dianne Nabuurs
    Cardigan, PE

    Joe Rowledge
    Charlottetown, PE

    Peter McCrady
    Cornwall, PE



Canadian Cancer Trials Group researcher Dr Wendy Parulekar The Canadian Cancer Trials Group found that extending hormone therapy keeps breast cancer at bay.

Learn more

Great progress has been made

Icon - arrow

Some cancers, such as thyroid and testicular, have survival rates of over 90%. Other cancers, such as pancreatic, brain and esophageal, continue to have very low survival rates.

Learn more